44 participants
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2025-12-11
- Completion:
- 2027-05-01
Conditions
- Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet